Skip to main content

Table 2 Results of primary analyses of GDM and control groups

From: Subclinical inflammation associated with prolonged TIMP-1 upregulation and arterial stiffness after gestational diabetes mellitus: a hospital-based cohort study

 

GDM

Controls

p value

hsCRP, mg/L

2.50 ± 3.69

2.50 ± 4.19

0.582

MMP-8, ng/mL

27.83 ± 1.48

32.78 ± 1.90

0.082

MMP-9, ng/mL

384.27 ± 13.15

392.15 ± 12.60

0.667

TIMP-1, ng/mL

102.80 ± 29.72

94.58 ± 24.51

0.020

MMP-8/TIMP-1, mol ratio

0.13 ± 0.009

0.17 ± 0.015

0.035

MMP-9/TIMP-1, mol ratio

1.32 ± 0.078

1.43 ± 0.085

0.152

C1, mL/mmHg × 10

15.14 ± 3.51

15.85 ± 3.36

0.092

C2, mL/mmHg × 100

8.44 ± 3.08

8.60 ± 3.20

0.681

PWV, m/s

6.44 ± 0.83

6.17 ± 0.74

0.009

  1. Data are presented as mean ± SD
  2. hsCRP high-sensitivity C reactive protein, C1 large artery compliance index, C2 small artery compliance index, PWV pulse wave velocity, MMP-8 matrix metalloproteinase-8, MMP-9 matrix metalloproteinase-9